Nanosilver Fluoride
纳米氟化银
Report date: 2022/03/11 14:10:07
NME
Base Information
Drug NameNanosilver Fluoride
Drug Alias Name
Classification
Mechanisms of Action
Targets
Therapy Area/Indications
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/Territory
CombinationsNo
Global Highest StatusPhase 3 Clinical
Highest Status in ChinaN/A
Originator CompaniesAlexandria University
China Registration ClassN/A
Develop Information
Active CompaniesPlovdiv Medical UniversityAlexandria University
Inactive CompaniesUniversity Of Pernambuco
Active Indications
Inactive IndicationsN/A
Other Information
ATC CodeN/A
Related LinksN/A